Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 11/20 | 0.83 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HAO1 | Q9UJM8 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.47 |
| ▸ | FEN1 | P39748 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL205280 | 0.92 | GSK3B (0.80) | GSK3BPTPN1RAB9A | |
| SCHEMBL15395891 | 0.91 | GSK3B (0.70) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL22004470 | 0.91 | GSK3B (1.00) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL973263 | 0.91 | GSK3B (0.87) | GSK3BPTPN1HAO1 | |
| SCHEMBL316871 | 0.91 | GSK3B (1.00) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL7376309 | 0.89 | GSK3B (0.68) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL8213015 | 0.89 | GSK3B (0.88) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL8793197 | 0.89 | PTPN1 (0.88) | GSK3BPTPN1RAB9A | |
| SCHEMBL18209648 | 0.89 | GSK3B (0.68) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 | |
| SCHEMBL13557299 | 0.89 | GSK3B (0.68) | GSK3BPTPN1SMN1; SMN2MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529815-A | Acidizing corrosion inhibitor, acidizing working solution, and preparation method and application thereof | 西安石油大学 | 2025-02-28 | — | — | CN | claimed |
| CN-108727171-B | Preparation method of 4,4' -di (2-bromoacetyl) biphenyl | 上海迪赛诺化学制药有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-110878090-B | One-pot preparation process of NS5A protein inhibitor Daclatasvir | 南通常佑药业科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| WO-2016079697-A1 | PROCESS FOR THE PREPARATION OF AN INTERMEDIATE OF DACLATASVIR DIHYDROCHLORIDE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2016-05-26 | — | — | WO | claimed |
| US-4692530-A | Chemical agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-09-08 | — | — | US | claimed |
| CN-119529815-A | Acidizing corrosion inhibitor, acidizing working solution, and preparation method and application thereof | 西安石油大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119529815-A | Acidizing corrosion inhibitor, acidizing working solution, and preparation method and application thereof | 西安石油大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-118894990-A | Poly (alpha-ketoselenoamide) compound and preparation method and application thereof | 华南理工大学 | 2024-11-05 | — | — | CN | disclosed |
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-06-27 | — | — | US | disclosed |
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-06-27 | — | — | US | disclosed |
| EP-4212180-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | The Scripps Research Institute (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-108727171-B | Preparation method of 4,4' -di (2-bromoacetyl) biphenyl | 上海迪赛诺化学制药有限公司 | 2023-06-16 | — | — | CN | disclosed |
| US-4946962-A | USED IN GRAPHIC ARTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-08-07 | — | — | US | disclosed |
| EP-0225804-B1 | THIAZOLINETHIONE-CONTAINING POLYMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-01-31 | — | — | EP | disclosed |
| EP-0239369-A1 | Bis (thiazolinethiones) | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-09-30 | — | — | EP | disclosed |
| US-4692530-A | Chemical agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-09-08 | — | — | US | disclosed |
| US-4659801-A | Thiazolinethione-containing polymer | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| US-4454304-A | CONJUGATED DIENE RUBBER BLENDS | COPOLYMER RUBBER & CHEMICAL CORP. (US) | 1984-06-12 | — | — | US | disclosed |
| US-4222906-A | ADDING THE CATIONIC POLYMER DURING A SECOND STAGE OF MIXING | POLYSAR LIMITED (CA) | 1980-09-16 | — | — | US | disclosed |
| US-4133953-A | Process for the preparation of sulfonated benzofuran derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | SGMS1, SGMS2, PHOSPHO1 | GSK3B 3889/4885PTPN1 3543/4885SMN1; SMN2 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.